Fate Therapeutics (FATE) Institutional Ownership $1.01 +0.04 (+3.81%) Closing price 09/5/2025 04:00 PM EasternExtended Trading$1.00 -0.01 (-0.50%) As of 09/5/2025 06:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Fate Therapeutics (NASDAQ:FATE)CurrentInstitutional OwnershipPercentage97.54%Number ofInstitutional Buyers(last 12 months)59TotalInstitutional Inflows(last 12 months)$20.20MNumber ofInstitutional Sellers(last 12 months)40TotalInstitutional Outflows(last 12 months)$22.65M Get FATE Insider Trade Alerts Want to know when executives and insiders are buying or selling Fate Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data FATE Institutional Buying and Selling by Quarter Fate Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/26/2025 Thrivent Financial for Lutherans37,116$41K0.0%-58.4%0.032% 8/16/2025 Headlands Technologies LLC49,556$56K0.0%N/A0.043% 8/15/2025 BNP Paribas Financial Markets287,412$322K0.0%-16.0%0.249% 8/15/2025 Bridgeway Capital Management LLC25,000$28K0.0%N/A0.022% 8/15/2025 Bruce & Co. Inc.429,188$481K0.2%-22.0%0.372% 8/15/2025 Bank of America Corp DE122,130$137K0.0%-68.6%0.106% 8/15/2025 Ameriprise Financial Inc.339,714$380K0.0%-17.4%0.295% 8/14/2025 Jane Street Group LLC465,820$522K0.0%+631.4%0.406% 8/14/2025 Sei Investments Co.67,721$76K0.0%N/A0.059% 8/13/2025 Invesco Ltd.255,372$286K0.0%+19.6%0.223% Get the Latest News and Ratings for FATE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/12/2025 XTX Topco Ltd432,328$484K0.0%-5.9%0.377% 8/12/2025 JPMorgan Chase & Co.58,574$66K0.0%-98.3%0.051% 8/8/2025 Geode Capital Management LLC2,429,167$2.72M0.0%+7.0%2.120% 8/7/2025 Monaco Asset Management SAM675,000$756K0.1%-41.3%0.589% 8/7/2025 Acadian Asset Management LLC2,459,954$2.75M0.0%-0.6%2.147% 8/6/2025 Savant Capital LLC24,205$27K0.0%N/A0.021% 7/25/2025 Vanguard Personalized Indexing Management LLC71,364$80K0.0%+65.6%0.062% 7/15/2025 Public Employees Retirement System of Ohio113,655$127K0.0%-30.1%0.099% 7/11/2025 Assenagon Asset Management S.A.212,342$238K0.0%-29.9%0.185% 5/29/2025 Rhumbline Advisers150,248$119K0.0%-5.6%0.131% 5/21/2025 Acadian Asset Management LLC2,473,565$1.95M0.0%+67.8%2.158% 5/19/2025 Jane Street Group LLC63,691$50K0.0%+106.9%0.056% 5/16/2025 Goldman Sachs Group Inc.2,458,974$1.94M0.0%-0.7%2.146% 5/16/2025 Jacobs Levy Equity Management Inc.2,203,323$1.74M0.0%+38.8%1.923% 5/16/2025 AQR Capital Management LLC585,025$462K0.0%+296.4%0.510% 5/15/2025 Vestal Point Capital LP2,515,850$1.99M0.1%+2.1%2.195% 5/15/2025 Caption Management LLC57,000$45K0.0%N/A0.050% 5/14/2025 Comerica Bank82,024$65K0.0%+55,698.6%0.072% 5/14/2025 Walleye Capital LLC72,286$57K0.0%-93.3%0.063% 5/14/2025 Bruce & Co. Inc.550,000$434K0.1%+57.1%0.480% 5/13/2025 Russell Investments Group Ltd.79,377$63K0.0%-11.6%0.069% 5/13/2025 Callan Family Office LLC82,024$65K0.0%N/A0.072% 5/12/2025 Nuveen LLC379,088$300K0.0%N/A0.331% 5/12/2025 Invesco Ltd.213,503$169K0.0%+96.0%0.186% 5/9/2025 Charles Schwab Investment Management Inc.703,825$556K0.0%-8.6%0.614% 5/9/2025 Privium Fund Management B.V.109,026$86K0.0%+25.3%0.095% 5/8/2025 Monaco Asset Management SAM1,149,708$908K0.2%+250.9%1.003% 5/8/2025 XTX Topco Ltd459,308$363K0.0%+83.9%0.401% 5/1/2025 CWM LLC41,435$33K0.0%+899.6%0.036% 4/17/2025 Exchange Traded Concepts LLC131,830$104K0.0%+211.7%0.115% 4/15/2025 Assenagon Asset Management S.A.302,899$239K0.0%-18.7%0.264% 2/19/2025 Public Employees Retirement System of Ohio88,766$146K0.0%-34.2%0.078% 2/17/2025 Woodline Partners LP1,422,785$2.35M0.0%-53.6%1.249% 2/17/2025 Vestal Point Capital LP2,465,000$4.07M0.2%+46.3%2.164% 2/17/2025 Squarepoint Ops LLC34,295$57K0.0%+154.2%0.030% 2/17/2025 Two Sigma Investments LP297,106$490K0.0%-35.4%0.261% 2/17/2025 Two Sigma Advisers LP828,100$1.37M0.0%-10.7%0.727% 2/17/2025 Tang Capital Management LLC1,855,954$3.06M0.2%+165.1%1.630% 2/17/2025 Sphera Funds Management LTD.397,177$655K0.1%N/A0.349% 2/17/2025 Redmile Group LLC12,872,946$21.24M1.5%-2.2%11.303% 2/17/2025 Point72 Asia Singapore Pte. Ltd.33,094$55K0.0%N/A0.029% 2/17/2025 ProShare Advisors LLC33,645$56K0.0%+77.9%0.030% 2/17/2025 Millennium Management LLC413,192$682K0.0%+28.9%0.363% 2/17/2025 Integral Health Asset Management LLC600,000$990K0.1%-38.5%0.527% 2/17/2025 Graham Capital Management L.P.22,342$37K0.0%N/A0.020% 2/17/2025 D. E. Shaw & Co. Inc.1,536,633$2.54M0.0%-54.5%1.349% 2/17/2025 Brevan Howard Capital Management LP24,636$41K0.0%N/A0.022% 2/17/2025 Baker BROS. Advisors LP3,258,402$5.38M0.1%+8.7%2.861% 2/17/2025 Bank of America Corp DE304,129$502K0.0%-64.4%0.267% 2/17/2025 BNP Paribas Financial Markets287,711$475K0.0%+65.2%0.253% 2/17/2025 Ameriprise Financial Inc.177,161$292K0.0%-29.1%0.156% 2/14/2025 Jane Street Group LLC30,780$51K0.0%-79.2%0.027% 2/14/2025 Northern Trust Corp805,518$1.33M0.0%-1.2%0.707% 2/14/2025 Susquehanna Fundamental Investments LLC118,186$195K0.0%N/A0.104% 2/14/2025 Price T Rowe Associates Inc. MD38,049$63K0.0%-41.7%0.033% 2/14/2025 Dark Forest Capital Management LP61,220$101K0.0%+128.0%0.054% 2/14/2025 Hsbc Holdings PLC109,422$179K0.0%+22.0%0.096% 2/14/2025 MetLife Investment Management LLC16,641$27K0.0%-61.0%0.015% 2/14/2025 Dimensional Fund Advisors LP2,898,377$4.78M0.0%+10.7%2.545% 2/13/2025 CANADA LIFE ASSURANCE Co21,267$35K0.0%-53.4%0.019% 2/13/2025 Marshall Wace LLP512,641$846K0.0%N/A0.450% 2/13/2025 Walleye Capital LLC1,083,092$1.79M0.0%+1,502.0%0.951% 2/13/2025 XTX Topco Ltd249,800$412K0.0%N/A0.219% 2/13/2025 Renaissance Technologies LLC378,619$625K0.0%+4.4%0.332% 2/13/2025 Cerity Partners LLC823,134$1.36M0.0%+4,953.6%0.723% 2/13/2025 Federated Hermes Inc.543,021$896K0.0%-1.8%0.477% 2/13/2025 Aristides Capital LLC100,555$166K0.0%N/A0.088% 2/13/2025 Russell Investments Group Ltd.89,823$148K0.0%+42.9%0.079% 2/13/2025 Wells Fargo & Company MN92,395$152K0.0%+56.3%0.081% 2/12/2025 Geode Capital Management LLC2,226,967$3.68M0.0%-1.4%1.955% 2/12/2025 Franklin Resources Inc.165,353$273K0.0%+9.6%0.145% 2/12/2025 BIT Capital GmbH247,564$408K0.0%N/A0.217% 2/12/2025 JPMorgan Chase & Co.1,669,562$2.76M0.0%-9.1%1.466% 2/11/2025 Prudential Financial Inc.321,401$530K0.0%-9.9%0.282% 2/11/2025 Vanguard Group Inc.10,333,033$17.05M0.0%-0.7%9.073% 2/11/2025 LPL Financial LLC73,120$121K0.0%N/A0.064% 2/11/2025 American Century Companies Inc.197,704$326K0.0%+6.6%0.174% 2/11/2025 Privium Fund Management B.V.87,000$144K0.0%+74.0%0.076% 2/11/2025 Intech Investment Management LLC39,443$65K0.0%+27.5%0.035% 2/10/2025 Thrivent Financial for Lutherans89,322$148K0.0%-28.8%0.078% 2/10/2025 Monaco Asset Management SAM327,671$541K0.1%+138.0%0.288% 2/7/2025 E Fund Management Co. Ltd.339,994$561K0.0%-3.9%0.299% 2/4/2025 Y Intercept Hong Kong Ltd35,360$58K0.0%N/A0.031% 2/4/2025 FPC Investment Advisory Inc.26,456$44K0.0%N/A0.023% 1/28/2025 Leo Wealth LLC70,439$116K0.0%+574.8%0.062% 1/24/2025 China Universal Asset Management Co. Ltd.24,150$40K0.0%N/A0.021% 1/23/2025 Institute for Wealth Management LLC.66,886$110K0.0%N/A0.059% 1/17/2025 SG Americas Securities LLC44,874$74K0.0%+30.6%0.039% 1/14/2025 Assenagon Asset Management S.A.372,507$615K0.0%-84.7%0.327% 12/26/2024 JPMorgan Chase & Co.1,837,304$6.43M0.0%+18.2%1.613% (Data available from 1/1/2016 forward) FATE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of FATE shares? During the previous two years, 125 institutional investors and hedge funds held shares of Fate Therapeutics. The most heavily invested institutionals were Bellevue Group AG ($35.52M), Redmile Group LLC ($21.24M), State Street Corp ($18.39M), Vanguard Group Inc. ($17.05M), Deerfield Management Company L.P. Series C ($11.66M), Baker BROS. Advisors LP ($5.38M), and Dimensional Fund Advisors LP ($4.78M).Learn more on Fate Therapeutics' institutional investors. What percentage of Fate Therapeutics' stock is owned by institutional investors? 97.54% of Fate Therapeutics' stock is owned by institutional investors. Learn more on FATE's institutional investor holdings. Which institutional investors have been buying Fate Therapeutics' stock? Of the 101 institutional investors that purchased Fate Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Assenagon Asset Management S.A. ($2.69M), Acadian Asset Management LLC ($2.53M), Monaco Asset Management SAM ($2.19M), Vestal Point Capital LP ($2.12M), Baker BROS. Advisors LP ($2.08M), Deerfield Management Company L.P. Series C ($1.37M), and Dimensional Fund Advisors LP ($1.35M). How much institutional buying is happening at Fate Therapeutics? Institutional investors have bought a total of 13,248,824 shares in the last 24 months. This purchase volume represents approximately $20.20M in transactions. Which of Fate Therapeutics' major shareholders have been selling company stock? Of the 40 institutional investors that sold Fate Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: JPMorgan Chase & Co. ($3.51M), Assenagon Asset Management S.A. ($2.36M), D. E. Shaw & Co. Inc. ($1.84M), Woodline Partners LP ($1.64M), Walleye Capital LLC ($1.01M), Bank of America Corp DE ($816.38K), and Monaco Asset Management SAM ($474.71K). How much institutional selling is happening at Fate Therapeutics? Institutional investors have sold a total of 14,568,439 shares in the last 24 months. This volume of shares sold represents approximately $22.65M in transactions. Related Companies Tectonic Therapeutic Major Shareholders Kodiak Sciences Major Shareholders Eton Pharmaceuticals Major Shareholders Arcturus Therapeutics Major Shareholders REGENXBIO Major Shareholders iTeos Therapeutics Major Shareholders Esperion Therapeutics Major Shareholders Cullinan Therapeutics Major Shareholders Erasca Major Shareholders CryoPort Major Shareholders This page (NASDAQ:FATE) was last updated on 9/7/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FATE Stock Alerts